Corient Private Wealth
CHRS icon

Corient Private Wealth’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Corient Private Wealth’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$43.9K Buy
60,000
+10,000
+20% +$7.31K ﹤0.01% 2487
2025
Q1 		$40.4K Hold
50,000
– – ﹤0.01% 2231
2024
Q4 		$69K Hold
50,000
– – ﹤0.01% 2253
2024
Q3 		$52K Buy
50,000
+20,000
+67% +$20.8K ﹤0.01% 2357
2024
Q2 		$51.9K Buy
+30,000
New +$51.9K ﹤0.01% 2250